Published in Cardiovasc Diabetol on September 07, 2009
Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol (2010) 1.08
Association of fibrinogen with severity of stable coronary artery disease in patients with type 2 diabetic mellitus. Dis Markers (2014) 0.87
Characterization of macro-and microvascular function and structure in patients with type 2 diabetes mellitus. Am J Cardiovasc Dis (2011) 0.86
Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction. Basic Res Cardiol (2013) 0.82
Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study. Cardiovasc Diabetol (2010) 0.81
Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study. Cardiovasc Diabetol (2012) 0.78
Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk. Cardiovasc Diabetol (2015) 0.77
Impact of sleeve gastrectomy on red blood cell aggregation: a 12-month follow-up study. Int J Obes (Lond) (2014) 0.75
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
[Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol (1957) 12.36
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation (1975) 10.97
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet (2002) 5.77
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med (1995) 5.24
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest (1985) 3.85
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation (1993) 3.54
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16
Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med (1993) 3.02
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med (1985) 2.39
Red blood cells express a functional endothelial nitric oxide synthase. Blood (2005) 2.30
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet (1987) 2.23
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J (1991) 1.83
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis (1988) 1.30
Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens (1989) 1.24
Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes (2006) 1.22
Insulin secretion, insulin resistance, and obesity. Int J Obes (1982) 1.06
Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clin Res Cardiol (2008) 1.03
Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension (1985) 1.01
Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation (1995) 1.01
Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol (1983) 0.97
High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol (2006) 0.97
Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study. J Chronic Dis (1983) 0.95
Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes (1993) 0.94
Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost (1993) 0.92
Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study. Metabolism (1994) 0.90
Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2. Cardiovasc Diabetol (2009) 0.89
Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy. Arterioscler Thromb Vasc Biol (2008) 0.88
Hypertriglyceridemia: mechanisms, clinical significance, and treatment. Med Clin North Am (1982) 0.87
Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study. Int J Obes (1988) 0.87
Effects of acute insulin-induced hypoglycaemia on haemostasis, fibrinolysis and haemorheology in insulin-dependent diabetic patients and control subjects. Clin Sci (Lond) (1991) 0.86
Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group. J Intern Med (1995) 0.81
Effects of fibrinogen and alpha2-macroglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates. Ther Apher Dial (2008) 0.80
Insulin and atherosclerosis. Lancet (1969) 0.80
The hemorheological aspects of the metabolic syndrome are a combination of separate effects of insulin resistance, hyperinsulinemia and adiposity. Clin Hemorheol Microcirc (2006) 0.79
Hemorheological disorders during ischemic brain infarcts in patients with and without diabetes mellitus. Clin Hemorheol Microcirc (2006) 0.79
Hemorheological disorders in patients with type 1 or 2 diabetes mellitus and foot gangrene. Clin Hemorheol Microcirc (2006) 0.79
Diabetes and coronary heart disease. Acta Endocrinol Suppl (Copenh) (1985) 0.79
Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia. Thromb Haemost (1997) 0.78
Increased red cell aggregation is correlated with HbA1C and lipid levels in type 1 but not type 2 diabetes. Clin Hemorheol Microcirc (2006) 0.78
A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100. Arterioscler Thromb (1993) 0.77
Left ventricular diastolic function in physiologic and pathologic hypertrophy. Am J Hypertens (2002) 1.42
Left ventricular hypertrophy and diastolic dysfunction in healthy pregnant women. Cardiology (2002) 1.08
Primary malignant pericardial mesothelioma - a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case report. J Med Case Rep (2009) 1.05
First experiences for pulmonary vein isolation with the high-density mesh ablator (HDMA): a novel mesh electrode catheter for both mapping and radiofrequency delivery in a single unit. J Cardiovasc Electrophysiol (2008) 0.98
Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra-ventricular tachycardia. results from a large retrospective patient cohort. Int J Med Sci (2009) 0.90
Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2. Cardiovasc Diabetol (2009) 0.89
Quality of life and occurrence of atrial fibrillation in long-term follow-up of common type atrial flutter ablation: ablation with irrigated 5 mm tip and conventional 8 mm tip electrodes. Clin Res Cardiol (2007) 0.87
Segmental pulmonary vein isolation in atrial fibrillation: new insights from the high density mesh mapper technique in an electrophysiologically guided approach. J Interv Card Electrophysiol (2009) 0.86
Massive pericarditis constrictiva calcarea with compression of the right ventricle and consecutive pulmonary embolism. Eur J Echocardiogr (2009) 0.82
Pulmonary vein isolation in 2012: is it necessary to perform a time consuming electrophysical mapping or should we focus on rapid and safe therapies? A retrospective analysis of different ablation tools. Int J Med Sci (2012) 0.82
Systolic and early diastolic left ventricular velocities assessed by tissue Doppler imaging in 100 top-level handball players. Eur J Cardiovasc Prev Rehabil (2010) 0.79
Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol (2009) 0.79
Segment-orientated analysis of two-dimensional strain and strain rate as assessed by velocity vector imaging in patients with acute myocardial infarction. Int J Med Sci (2011) 0.79
New-onset versus chronic atrial fibrillation in acute myocardial infarction: differences in short- and long-term follow-up. Clin Res Cardiol (2010) 0.78
Parameters of left ventricular diastolic function 48 hours after coronary angioplasty and stent implantation. J Invasive Cardiol (2003) 0.78
Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" - not "end-stage" after all. BMC Cardiovasc Disord (2009) 0.77
Multiple cardiac metastases from a malignant melanoma causing consecutive pulmonary embolism. Herz (2009) 0.75
[The current status of noninvasive cardiac diagnosis in women with suspected coronary heart disease]. Med Klin (Munich) (2002) 0.75
Impact of irrigated energy application on the right coronary artery hemodynamics: FFR measurement in patients who underwent ablation of common type atrial flutter. J Interv Card Electrophysiol (2008) 0.75